Viewing Study NCT05278351

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:42 PM

Ignite Modification Date: 2025-12-25 @ 9:33 PM

Study NCT ID: NCT05278351

Status: UNKNOWN

Last Update Posted: 2023-03-31

First Post: 2022-03-08

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC

Sponsor: Shanghai Zhongshan Hospital

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module